Table 5.
Item | CP contents (g/kg of DM)1 | Contrast2 | ||||||
---|---|---|---|---|---|---|---|---|
CR | 100 | 120 | 140 | SEM | RI vs. VI | Linear | Quadratic | |
Apparent absorption of NEAA (g/d) | ||||||||
Alanine | 16.6 | 28.2 | 34.0 | 38.9 | 0.003 | <0.01 | <0.01 | 0.81 |
Aspartic acid | 26.3 | 43.1 | 51.2 | 57.8 | 0.01 | <0.01 | 0.01 | 0.87 |
Cystine | 5.2 | 7.2 | 70 | 8.5 | 1.81 | <0.01 | 0.13 | 0.25 |
Glutamic acid | 36.3 | 58.7 | 70.0 | 78.3 | 0.01 | <0.01 | <0.01 | 0.78 |
Glycine | 12.5 | 21.3 | 26.7 | 30.0 | 0.003 | <0.01 | <0.01 | 0.54 |
Proline | 12.0 | 21.3 | 27.0 | 29.4 | 0.002 | <0.01 | <0.01 | 0.34 |
Serine | 12.2 | 19.1 | 23.4 | 27.5 | 0.002 | <0.01 | <0.01 | 0.92 |
Tyrosine | 11.7 | 17.7 | 20.2 | 24.2 | 0.002 | <0.01 | <0.01 | 0.60 |
Apparent digestibility of NEAA (%) | ||||||||
Alanine | 66.8 | 67.5 | 71.5 | 70.8 | 2.35 | 0.01 | 0.02 | 0.05 |
Aspartic acid | 79.1 | 77.4 | 81.2 | 77.6 | 3.39 | 0.84 | 0.93 | 0.07 |
Cystine | 68.7 | 64.1 | 61.1 | 68.0 | 11.08 | 0.34 | 0.48 | 0.30 |
Glutamic acid | 72.3 | 70.7 | 75.6 | 73.3 | 2.12 | 0.50 | 0.12 | 0.02 |
Glycine | 60.6 | 60.9 | 66.1 | 65.6 | 2.83 | 0.01 | 0.01 | 0.05 |
Proline | 62.3 | 63.4 | 69.4 | 68.5 | 2.60 | <0.01 | <0.01 | 0.02 |
Serine | 69.8 | 67.6 | 73.1 | 72.3 | 2.26 | 0.41 | 0.01 | 0.04 |
Tyrosine | 68.3 | 65.3 | 68.5 | 67.6 | 2.68 | 0.51 | 0.28 | 0.26 |
Total NEAA | 68.9 | 73.4 | 71.9 | 70.0 | 0.02 | 0.27 | 0.06 | 0.03 |
Total AA | ||||||||
Ap.Ab3 (g/d) | 249.8 | 406.8 | 476.0 | 554.0 | 0.04 | <0.01 | <0.01 | 0.89 |
AD4 (%) | 71.2 | 70.2 | 74.2 | 73.4 | 0.02 | 0.30 | 0.06 | 0.10 |
1Treatments: RI = restricted intake to 1.2% BW containing 120 g of CP/kg of DM; 100, 120, and 140 = voluntary intake containing 100, 120, and 140 g of CP/kg of DM, respectively.
2RI vs. VI = restricted intake vs. voluntary intake (100, 120, and 140 CP g of CP/kg of DM).
3Ap.Ab = apparent absorption.
4AD = apparent digestibility.